Latest stories on FBIO
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Business Insider56 · neutralgeneral
Fortress Biotech: Cash Above Market Cap And Royalty Upside Make This A Speculative Buy
Seeking Alpha63 · neutralanalyst
Forget AMD: Choose This Blue-Chip Haven to Lock in Fortress Gains Amid Tech Volatility
Yahoo Top58 · neutralanalyst
Fortress Biotech, Inc. (FBIOP) files 8-K
SEC 8-K50 · neutralgeneral
Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends?
Seeking Alpha56 · neutralgeneral